Plain-English translation of NCT07015567 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether specially designed therapy modules can help refugees and asylum seekers who are experiencing complex post-traumatic stress disorder (CPTSD)—a serious condition caused by severe, prolonged trauma. The therapy being tested is tailored to respect cultural backgrounds and life circumstances, combining skills to manage emotions with guided storytelling about traumatic experiences. Researchers want to see which combination of these therapeutic approaches works best for people who have fled their home countries.
Many refugees experience severe, lasting trauma from events like torture and violence, which current treatments haven't been thoroughly tested for in this population. This trial exists to find out whether culturally adapted versions of this treatment can actually reduce symptoms and help displaced people heal and rebuild their lives.
You likely qualify if…
You likely don't qualify if…
You would first participate in an assessment phase to confirm your diagnosis. If you qualify, you would then be randomly assigned to receive therapy modules delivered in a sequence tailored for your needs—each module focuses on different skills like managing emotions, healing relationships, or processing traumatic memories through storytelling. Sessions would be conducted by trained therapists in your preferred language, and your progress would be tracked throughout the treatment period.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
Germany
Switzerland